Marleen Kars

2.4k total citations
25 papers, 1.8k citations indexed

About

Marleen Kars is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Occupational Therapy. According to data from OpenAlex, Marleen Kars has authored 25 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Endocrinology, Diabetes and Metabolism, 10 papers in Surgery and 5 papers in Occupational Therapy. Recurrent topics in Marleen Kars's work include Pituitary Gland Disorders and Treatments (10 papers), Diabetic Foot Ulcer Assessment and Management (7 papers) and Adrenal and Paraganglionic Tumors (6 papers). Marleen Kars is often cited by papers focused on Pituitary Gland Disorders and Treatments (10 papers), Diabetic Foot Ulcer Assessment and Management (7 papers) and Adrenal and Paraganglionic Tumors (6 papers). Marleen Kars collaborates with scholars based in Netherlands, United States and Italy. Marleen Kars's co-authors include Nicolaas C. Schaper, Alberto M. Pereira, Johannes A. Romijn, Samuel Klein, Bettina Mittendorfer, Bruce W. Patterson, Volkert Siersma, P. Holstein, Paul P.C.A. Menheere and Hans H. C. M. Savelberg and has published in prestigious journals such as Gastroenterology, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Marleen Kars

24 papers receiving 1.7k citations

Peers

Marleen Kars
Stewart G. Albert United States
Adam Gordois United Kingdom
Arja Nenonen Finland
P. C. OʼBrien United States
Stewart G. Albert United States
Marleen Kars
Citations per year, relative to Marleen Kars Marleen Kars (= 1×) peers Stewart G. Albert

Countries citing papers authored by Marleen Kars

Since Specialization
Citations

This map shows the geographic impact of Marleen Kars's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marleen Kars with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marleen Kars more than expected).

Fields of papers citing papers by Marleen Kars

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marleen Kars. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marleen Kars. The network helps show where Marleen Kars may publish in the future.

Co-authorship network of co-authors of Marleen Kars

This figure shows the co-authorship network connecting the top 25 collaborators of Marleen Kars. A scholar is included among the top collaborators of Marleen Kars based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marleen Kars. Marleen Kars is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mols, Floortje, Dounya Schoormans, Romana T. Netea‐Maier, et al.. (2023). Determinants and mediating mechanisms of quality of life and disease-specific symptoms among thyroid cancer patients: the design of the WaTCh study. Thyroid Research. 16(1). 23–23. 4 indexed citations
2.
Pickwell, K., et al.. (2019). Regional differences in cell‐mediated immunity in people with diabetic peripheral neuropathy. Diabetic Medicine. 37(2). 350–355. 1 indexed citations
3.
Siersma, Volkert, Hanne Thorsen, P. Holstein, et al.. (2017). Diabetic complications do not hamper improvement of health-related quality of life over the course of treatment of diabetic foot ulcers – the Eurodiale study. Journal of Diabetes and its Complications. 31(7). 1145–1151. 23 indexed citations
4.
Broeders, Evie P. M., Guy H. E. J. Vijgen, Bas Havekes, et al.. (2016). Thyroid Hormone Activates Brown Adipose Tissue and Increases Non-Shivering Thermogenesis - A Cohort Study in a Group of Thyroid Carcinoma Patients. PLoS ONE. 11(1). e0145049–e0145049. 58 indexed citations
5.
Pickwell, K., Volkert Siersma, Marleen Kars, et al.. (2016). Minor amputation does not negatively affect health‐related quality of life as compared with conservative treatment in patients with a diabetic foot ulcer: An observational study. Diabetes/Metabolism Research and Reviews. 33(3). 27 indexed citations
6.
Pickwell, K., Volkert Siersma, Marleen Kars, et al.. (2015). Predictors of Lower-Extremity Amputation in Patients With an Infected Diabetic Foot Ulcer. Diabetes Care. 38(5). 852–857. 146 indexed citations
7.
Pickwell, K., Volkert Siersma, Marleen Kars, P. Holstein, & Nicolaas C. Schaper. (2013). Diabetic foot disease: impact of ulcer location on ulcer healing. Diabetes/Metabolism Research and Reviews. 29(5). 377–383. 99 indexed citations
8.
Siersma, Volkert, Hanne Thorsen, P. Holstein, et al.. (2013). Health-Related Quality of Life Predicts Major Amputation and Death, but Not Healing, in People With Diabetes Presenting With Foot Ulcers: The Eurodiale Study. Diabetes Care. 37(3). 694–700. 66 indexed citations
9.
Geerts, Margot, et al.. (2012). Effective Pharmacological Treatment of Painful Diabetic Neuropathy by Nurse Practitioners: Results of an Algorithm-Based Experience. Pain Medicine. 13(10). 1324–1333. 5 indexed citations
10.
Amaro, Anastassia, Elisa Fabbrini, Marleen Kars, et al.. (2010). Dissociation Between Intrahepatic Triglyceride Content and Insulin Resistance in Familial Hypobetalipoproteinemia. Gastroenterology. 139(1). 149–153. 95 indexed citations
11.
Kars, Marleen, Olaf M. Dekkers, Alberto M. Pereira, & J A Romijn. (2010). Update in prolactinomas.. PubMed. 68(3). 104–12. 35 indexed citations
12.
Kars, Marleen, Ling Yang, Margaret F. Gregor, et al.. (2010). Tauroursodeoxycholic Acid May Improve Liver and Muscle but Not Adipose Tissue Insulin Sensitivity in Obese Men and Women. Diabetes. 59(8). 1899–1905. 329 indexed citations
13.
Kars, Marleen, Victoria Delgado, Eduard R. Holman, et al.. (2009). Aortic Valve Calcification and Mild Tricuspid Regurgitation But No Clinical Heart Disease After Eight Years of Dopamine Agonist Therapy for Prolactinoma. Obstetrical & Gynecological Survey. 64(2). 107–108.
14.
Kars, Marleen, Alberto M. Pereira, Jeroen J. Bax, & Johannes A. Romijn. (2008). Cabergoline and cardiac valve disease in prolactinoma patients: additional studies during long-term treatment are required. European Journal of Endocrinology. 159(4). 363–367. 53 indexed citations
15.
Klaauw, Agatha A. van der, Marleen Kars, Nienke R. Biermasz, et al.. (2008). Disease‐specific impairments in quality of life during long‐term follow‐up of patients with different pituitary adenomas. Clinical Endocrinology. 69(5). 775–784. 134 indexed citations
16.
Lange, Dylan W. de & Marleen Kars. (2008). Perioperative glucocorticosteroid supplementation is not supported by evidence. European Journal of Internal Medicine. 19(6). 461–467. 21 indexed citations
17.
Kars, Marleen, Alberto M. Pereira, Johannes W. A. Smit, & Johannes A. Romijn. (2008). Long-term outcome of patients with macroprolactinomas initially treated with dopamine agonists. European Journal of Internal Medicine. 20(4). 387–393. 19 indexed citations
18.
Kars, Marleen, Victoria Delgado, Eduard R. Holman, et al.. (2008). Aortic Valve Calcification and Mild Tricuspid Regurgitation But No Clinical Heart Disease after 8 Years of Dopamine Agonist Therapy for Prolactinoma. The Journal of Clinical Endocrinology & Metabolism. 93(9). 3348–3356. 93 indexed citations
19.
Kars, Marleen, et al.. (2007). Quality of life is decreased in female patients treated for microprolactinoma. European Journal of Endocrinology. 157(2). 133–139. 40 indexed citations
20.
Kars, Marleen, Ferdinand Roelfsema, Johannes A. Romijn, & Alberto M. Pereira. (2006). Malignant prolactinoma: case report and review of the literature. European Journal of Endocrinology. 155(4). 523–534. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026